Literature DB >> 28025372

A Pooled Analysis Evaluating Renal Safety in Placebo- and Active Comparator-Controlled Phase III Trials of Multiple-Dose Injectable HPβCD-Diclofenac in Subjects with Acute Postoperative Pain.

Stephen E Daniels1, Tong J Tj Gan2, Douglas A Hamilton3,4, Neil Singla5, Peter G Lacouture6,7, Olufunmibi Johnson8, Lauren H Min8, Christian R D Reyes8, Daniel B Carr9,10.   

Abstract

OBJECTIVE : While injectable nonsteroidal anti-inflammatory drugs (NSAIDs) are a key component of postoperative multimodal analgesia, renal safety concerns may limit use in some patients. This study examined the renal safety of injectable HPβCD-diclofenac when given for ≤ 5 days following orthopedic or abdominal/pelvic surgery. METHODS : Pooled analysis of data from two randomized, placebo- and active comparator-controlled phase III trials in 608 total patients was conducted. Renal safety was assessed by examining treatment-emergent adverse events (AEs) and postoperative blood urea nitrogen (BUN) and serum creatinine shifts. RESULTS : There were three renal AEs each in the HPβCD-diclofenac (n = 318 patients) and placebo (n = 148 patients) groups, and two renal AEs in the ketorolac group (n = 142 patients). No significant difference in renal AE risk was detected for patients receiving HPβCD-diclofenac (RR: 1.40 [0.15,13.3]; P = 0.75) or ketorolac (RR: 2.08 [0.19,22.7]; P = 0.56) versus placebo. All renal AEs were mild or moderate in severity, and a single renal AE (acute renal failure in a patient receiving HPβCD-diclofenac) was treatment-related. One incidence of postoperative shift to high (> upper limit of normal) serum creatinine occurred in the HPβCD-diclofenac group (n = 2 in the ketorolac group). Mean changes in serum creatinine or BUN did not differ significantly between patients receiving HPβCD-diclofenac and placebo. CONCLUSIONS : While this analysis examined relatively brief exposure typical for parenterally administered analgesics in the postoperative setting in patients with largely normal renal function, the results suggest that HPβCD-diclofenac use for acute postoperative pain may not be associated with added renal safety risks over placebo in this patient population.
© 2016 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Acute Pain; Diclofenac; NSAID; Pain Management; Renal; Safety

Mesh:

Substances:

Year:  2016        PMID: 28025372     DOI: 10.1093/pm/pnw146

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  7 in total

Review 1.  Single-dose intravenous ibuprofen for acute postoperative pain in adults.

Authors:  McKenzie C Ferguson; Roman Schumann; Sean Gallagher; Ewan D McNicol
Journal:  Cochrane Database Syst Rev       Date:  2021-09-09

Review 2.  Diclofenac Sodium Bolus Injection (Dyloject(TM)): A Review in Acute Pain Management.

Authors:  Sheridan M Hoy
Journal:  Drugs       Date:  2016-08       Impact factor: 9.546

Review 3.  Pushing the Envelope: Laparoscopic Nephrectomy as Outpatient Surgery.

Authors:  Nessn H Azawi; Tom Christensen; Claus Dahl; Lars Lund
Journal:  Curr Urol Rep       Date:  2018-01-27       Impact factor: 3.092

4.  Single-dose intravenous ketorolac for acute postoperative pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17

Review 5.  Single-dose intravenous diclofenac for acute postoperative pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2018-08-28

6.  Safety of Injectable HPβCD-Diclofenac in Older Patients with Acute Moderate-to-Severe Postoperative Pain: A Pooled Analysis of Three Phase III Trials.

Authors:  Jacques E Chelly; Peter G Lacouture; Christian Russel D Reyes
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

7.  Bibliometric and Visualized Analyses of Research Studies on Different Analgesics in the Treatment of Orthopedic Postoperative Pain.

Authors:  Yunzhong Cheng; Honghao Yang; Li Guan; Yong Hai; Aixing Pan
Journal:  Pain Res Manag       Date:  2022-02-24       Impact factor: 3.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.